AI Decision Intelligence for Biotech R&D

Make better AI implementation decisions. Then make the next one smarter.

Cellvara helps biotech R&D teams decide where and how AI should actually be implemented. It builds an understanding of your workflows, teams, data, systems and constraints, compares feasible AI approaches, turns the best option into an implementation-ready pilot, and learns from what actually happens during execution.

See pricing and pilot scope

Built for biotech SMEs & startups · Start with one R&D workflow · Evidence-backed decisions · Learns from every project

Cellvara · AI Decision Intelligence
CV
Cell Viability Assay Optimization
AI Opportunity

Scientific fit

High

Strong methodological match

Data readiness

Medium

Operator metadata incomplete

Implementation fit

High

Fits existing R&D workflow

Economic attractiveness

High

Clear iteration savings

#1

Recommended Approach

Structured DoE → Active Learning pilot. Decision: proceed with a staged pilot.

Pilot Roadmap

Backed by

Cellvara is part of Google for Startups, MongoDB for Startups, Claude for Startups, ElevenLabs Startup Grants and AWS for Startups.

Interactive prototype

See how Cellvara will look

Before the full product launches, try a clickable prototype. Follow a sample IL-6 ELISA with high background: Cellvara structures the lab data, traces the likely cause, ranks the fixes and drafts the next experiment. You check and approve every step.

About 5 minutes · fictional sample data

Try the prototype

Want it on your own lab data? Join the pilot program

cellvara.de/prototype
The Cellvara prototype explaining why the background is high in a sample ELISA run, with the reasoning traced through a knowledge graph
Let's Talk

Have an AI workflow you're unsure how to approach?

If your biotech R&D team is considering an AI initiative but is uncertain about feasibility, data readiness, the right technical approach or how to implement it, we would like to hear about it. Start with one workflow — we will help you determine whether AI is actually appropriate, which approaches are feasible, what could block implementation, and what a measurable pilot should look like.

Currently working with innovation-focused biotech R&D SMEs and startups.